Connect Biopharma Holdings Limited Operating Cash Flow
Connect Biopharma Holdings Limited (CNTB) reported Operating Cash Flow of -$31.93 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-12
- Connect Biopharma Holdings Limited net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$15.92M.
- Connect Biopharma Holdings Limited net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$16.00M.
- Connect Biopharma Holdings Limited net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$11.25M.
- Connect Biopharma Holdings Limited net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$17.41M.
- Connect Biopharma Holdings Limited net cash provided by (used in) operating activities for fiscal 2025 was -$51.21M.
- Connect Biopharma Holdings Limited net cash provided by (used in) operating activities for fiscal 2024 was -$23.61M.
- Connect Biopharma Holdings Limited net cash provided by (used in) operating activities for fiscal 2023 was -$47.74M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$15.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$31.93M 10-Q · filed 2026-08-12 | -$43.18M derived: sum of 3 quarters · filed 2026-08-12 | -$60.58M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$16.00M 10-Q · filed 2026-05-12 | -$27.25M derived: sum of 2 quarters · filed 2026-05-12 | -$44.66M derived: sum of 3 quarters · filed 2026-05-12 | -$57.25M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$11.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$28.66M derived: sum of 2 quarters · filed 2026-03-31 | -$41.25M derived: sum of 3 quarters · filed 2026-08-12 | -$51.21M 10-K · filed 2026-03-31 |
| 2025-09-30 | -$17.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$30.00M derived: sum of 2 quarters · filed 2026-08-12 | -$39.96M 10-Q · filed 2025-11-12 | -$42.27M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$12.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$22.55M 10-Q · filed 2026-08-12 | -$24.87M derived: sum of 3 quarters · filed 2026-08-12 | -$37.88M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$9.96M 10-Q · filed 2026-05-12 | -$12.28M derived: sum of 2 quarters · filed 2026-05-12 | -$25.29M derived: sum of 3 quarters · filed 2026-05-12 | -$32.98M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$15.33M derived: sum of 2 quarters · filed 2026-03-31 | -$23.02M derived: sum of 3 quarters · filed 2026-03-31 | -$23.61M 10-K · filed 2026-03-31 |
| 2024-09-30 | -$13.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$20.70M derived: sum of 2 quarters · filed 2025-11-12 | -$21.29M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$7.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$8.29M 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$591.00K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$47.74M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |